August Krogh Building
Copenhagen, 2100, Denmark
Location status: Recruiting
NCT Number: NCT06655012
The purpose of the project is to investigate the muscle anabolic response to acute beta2-adrenergic stimulation in young healthy men and women.
Interested in participating?
Request Info18 year–40 year
All sexes
Interventional
Not applicable
Copenhagen, 2100, Denmark
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants are administered 200 µg salmeterol (8 puffs) from a MDI device
Participants are administered placebo (8 puffs) from a MDI device
Time frame: Through study completion, an average on 2 weeks
Power output measured in Watts during a sprint on a bike ergometer
Time frame: Through study completion, an average on 2 weeks
Mean power output measured in Watts during a time trial on a bike ergometer
Time frame: Through study completion, an average on 2 weeks
Maksimal torque (Nm) achieved during isometric contraction
University of Copenhagen
Other
The Muscle Anabolic Response to β2-adrenergic Stimulation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686393
Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT07669077
Healthy
Salt Lake City, Utah, United States
View Trial DetailsNCT07169630
Alzheimer s Disease, Cognition Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT07739238
Healthy
Balıkesir, In the USA Or Canada, Please Select..., Turkey (Türkiye)
View Trial Details